Search the Newsreel

MEDP: Medpace Holdings Inc Latest Stock Price, Analysis, News and Trading Ideas

This article provides the latest stock information for Medpace Holdings Inc (MEDP), including its pre-market price, market capitalization, and key financial metrics. It also highlights recent news, such as Medpace beating Q2 earnings and revenue estimates, and identifies it as a top growth stock. …

Medpace (MEDP) Beats Q2 Earnings and Revenue Estimates

Medpace (MEDP) came out with quarterly earnings of $4.25 per share, beating the Zacks Consensus Estimate of $4.08 per share. This compares to earnings of $3.1 per share a year ago. These figures are adjusted for non-recurring items. This quarterly report represents an earnings …

Medpace Notches A Big Bookings Beat, And Reverses Its First-Quarter Malaise

Medpace Holdings stock surged by double digits late Wednesday, helped by a big bookings beat, rebounding from a poor start to the year. Then, the book-to-bill ratio came in at 0.88x and Medpace stock plummeted to a nine-month low. In after-hours trades on the …

Medpace surges on earnings beat and raised guidance By Investing.com

Medpace Holdings Inc. (NASDAQ:MEDP) reported strong second-quarter results, beating analyst expectations for earnings and revenue. The clinical research organization also issued full-year 2026 guidance that surpassed consensus estimates, leading to an 18.7% surge in shares during after-hours trading. The robust performance was driven by …

Medpace (NASDAQ:MEDP) Exceeds Q2 CY2026 Expectations, Stock Jumps 18.6%

Medpace Holdings (NASDAQ:MEDP) reported strong financial results for Q2 CY2026, with revenue of $707.3 million, exceeding analyst estimates by 2.6%. The company's GAAP EPS of $4.25 also beat consensus estimates by 6.6%. Following these positive results, Medpace raised its full-year revenue guidance to $2.85 …

Earnings Flash (MEDP) Medpace Holdings, Inc. Reports Q2 Revenue $707.3M, vs. FactSet Est of $689.5M

Medpace Holdings, Inc. (MEDP) announced Q2 revenue of $707.3 million, surpassing FactSet's estimate of $689.5 million. The company also anticipates full-year 2026 revenue to be between $2.81 billion and $2.89 billion, exceeding FactSet's estimate of $2.77 billion. Additionally, Medpace reported Q2 EPS of $4.25, …

(MEDP) Medpace Expects Full Year 2026 EPS Range $17.25 - $17.95, vs. FactSet Est of $16.97

Medpace Holdings, Inc. (MEDP) has provided its earnings per share (EPS) guidance for the full year 2026, anticipating a range of $17.25 to $17.95. This forecast surpasses the current FactSet estimate of $16.97. The news follows Medpace's Q2 earnings report, which indicated a rise …

Medpace To Report Q2 Results; Can Growth Sustain After A Strong Start To 2026?

(RTTNews) - Medpace Holdings, Inc. (MEDP) will report second-quarter 2026 results on July 22, 2026, with investors watching whether the contract research organization can extend the robust growth it delivered in Q1 and maintain its elevated backlog conversion pace. Revenue in the first quarter …

MEDPACE HOLDINGS ($MEDP) Releases Q2 2026 Earnings, Stock Rises

MedPlus Shares Fall Over 17% After Q1 Net Profit Declines 21%

MedPlus Health shares tumble 16% after Q1 profit falls 21% YoY. Should you buy, sell or hold?

Medplus Health Services shares tumble to 52-week low after weak Q1 FY27; Nomura maintains 'Buy', check target price

Medplus Health Services consolidated net profit declines 21.67% in the June 2026 quarter

MedPlus Health Shares Slide 16% on Q1 Profit Decline Despite Revenue Growth - Tech Earnings Analysis

Medpace stock trades near record levels as revenue and earnings accelerate

Medpace Holdings Inc. (MEDP) is experiencing strong growth, with its stock trading near record levels due to double-digit revenue expansion and rising profitability. The contract research organization reported a 22% revenue increase and a 28% EPS increase in Q1 2026, alongside a robust backlog …

MedPlus Health Q1 net profit falls 22% as margins decline despite 22% revenue growth

What To Expect From Medpace’s (MEDP) Q2 Earnings

Medpace Holdings (MEDP) is set to report its Q2 earnings this Wednesday. The company previously exceeded revenue expectations in Q1, and analysts anticipate a 14.3% year-on-year revenue growth for Q2. Investor sentiment for life sciences tools & services stocks has been positive, with Medpace's …

Medpace Holdings Q2 2026 Earnings Preview — July 23, Street Expects $4.00 EPS

Medpace Holdings (MEDP) is expected to report strong double-digit growth for its Q2 2026 earnings on July 23, with analysts forecasting $4.00 EPS on $688.8 million in revenue. This represents a significant year-over-year increase in both earnings and revenue, driven by anticipated margin expansion …

ETFs Investing in Medpace Holdings, Inc. Stocks

This article lists various Exchange Traded Funds (ETFs) that hold stocks of Medpace Holdings, Inc. It details each fund's market value, weight of Medpace stock, issuer, management style, focus, expense ratio, assets under management (AUM), price, change percentage, relative volume, and 3-year NAV total …

MedPal AI shares slide despite raising £5m to fund growth aspirations

Medplus Health Services Share Price Target 2026: Bull Case Rs 1,1295

Previsão EDPR — Preço Alvo para 2027

A sua semana dia a dia: EDPR entrega novas ações, BCP recompra títulos e Ibersol entra em ex-dividendo

MedPlus FY26 net profit rises 46.2% to ₹2,196.1m

Medplus Health Consolidated March 2026 Net Sales at Rs 1,864.39 crore, up 23.5% Y-o-Y

Medplus Health zooms 11% as Q4 profit jumps 25% YoY; revenue up 24%

With EPS Growth And More, MedPlus Health Services (NSE:MEDPLUS) Makes An Interesting Case

MedPlus Health Services Schedules Q4FY26 Earnings Call for May 21, 2026

MedPlus Health Services Subsidiary Faces Drug License Suspension in Karnataka

Stocks to Watch Today: Sun Pharma, Bajaj Auto, HBL Engg, OLA, IDFC First Bank, Blue Dart, MedPlus Health,...

MedPlus Health Q3 net profit surges 26% on higher sales and new stores

MedPlus Health Services Limited's (NSE:MEDPLUS) Stock Has Shown A Decent Performance: Have Financials A Role To Play?

Stock Alert: Bank of Baroda, Medplus Health Services, R R Kabel, Escorts Kubota

MedPlus Health Services First Quarter 2026 Earnings: EPS Beats Expectations

EDPR aprova aumento de capital para programa de "scrip dividend"